|
|
|
|
| LEADER |
01425nam a22004215i 4500 |
| 001 |
13162 |
| 003 |
DE-He213 |
| 005 |
20120817195247.0 |
| 007 |
cr nn 008mamaa |
| 008 |
120817s2013 xxu| s |||| 0|eng d |
| 020 |
# |
# |
|a 9781461448754
|9 978-1-4614-4875-4
|
| 024 |
7 |
# |
|a 10.1007/978-1-4614-4875-4
|2 doi
|
| 050 |
# |
4 |
|a RS380
|
| 050 |
# |
4 |
|a RS190-210
|
| 072 |
# |
7 |
|a TDCW
|2 bicssc
|
| 072 |
# |
7 |
|a MED072000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.19
|2 23
|
| 100 |
1 |
# |
|a De, Arnab.
|
| 245 |
1 |
0 |
|a Application of Peptide-Based Prodrug Chemistry in Drug Development
|c by Arnab De.
|h [electronic resource] /
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2013.
|
| 300 |
# |
# |
|b digital.
|
| 490 |
0 |
# |
|a SpringerBriefs in Pharmaceutical Science & Drug Development,
|x 1864-8118
|
| 650 |
# |
0 |
|a Medicine.
|
| 650 |
# |
0 |
|a Toxicology.
|
| 650 |
# |
0 |
|a Pharmaceutical technology.
|
| 650 |
# |
0 |
|a Diabetes.
|
| 650 |
1 |
4 |
|a Biomedicine.
|
| 650 |
2 |
4 |
|a Pharmaceutical Sciences/Technology.
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Diabetes.
|
| 710 |
2 |
# |
|a SpringerLink (Online service)
|
| 773 |
0 |
# |
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9781461448747
|
| 830 |
# |
0 |
|a SpringerBriefs in Pharmaceutical Science & Drug Development,
|x 1864-8118
|
| 856 |
4 |
0 |
|u https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-4614-4875-4
|
| 912 |
# |
# |
|a ZDB-2-SME
|
| 950 |
# |
# |
|a Medicine (Springer-11650)
|